These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27284161)
21. Raynaud's phenomenon. Herrick AL; Wigley FM Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400 [TBL] [Abstract][Full Text] [Related]
22. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Salerni R; Rodnan GP; Leon DF; Shaver JA Ann Intern Med; 1977 Apr; 86(4):394-9. PubMed ID: 848800 [TBL] [Abstract][Full Text] [Related]
23. Raynaud's phenomenon and systemic sclerosis. Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438 [TBL] [Abstract][Full Text] [Related]
24. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance. Klein-Weigel P; Opitz C; Riemekasten G Vasa; 2011 Jan; 40(1):6-19. PubMed ID: 21283969 [TBL] [Abstract][Full Text] [Related]
25. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches. Volkmann ER; Furst DE Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126 [TBL] [Abstract][Full Text] [Related]
26. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic. Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498 [TBL] [Abstract][Full Text] [Related]
27. French translation and linguistic validation of the Raynaud's condition score. Khouri C; Blaise S; Guigui A; Cracowski C; Allanore Y; Hachulla E; Senet P; Roustit M; Cracowski JL Therapie; 2019 Dec; 74(6):627-631. PubMed ID: 31023622 [TBL] [Abstract][Full Text] [Related]
28. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis. Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894 [TBL] [Abstract][Full Text] [Related]
29. Raising awareness of Raynaud's phenomenon and scleroderma. Mawdsley AH; Brown SJ Nurs Times; 2005 Feb 22-28; 101(8):30-1. PubMed ID: 15754937 [TBL] [Abstract][Full Text] [Related]
31. Current therapy of systemic sclerosis (scleroderma). Müller-Ladner U; Benning K; Lang B Clin Investig; 1993 Apr; 71(4):257-63. PubMed ID: 8471811 [TBL] [Abstract][Full Text] [Related]
32. Connective tissue diseases: New evidence-based guidelines for treating SSc. Pope JE Nat Rev Rheumatol; 2009 Jun; 5(6):300-2. PubMed ID: 19491908 [TBL] [Abstract][Full Text] [Related]
33. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis. O'Reilly D; Taylor L; el-Hadidy K; Jayson MI Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594 [TBL] [Abstract][Full Text] [Related]
34. Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc. Ikawa Y; Hamaguchi Y; Mugii N; Matsushita T; Takehara K Mod Rheumatol; 2017 Jul; 27(4):614-617. PubMed ID: 27830961 [TBL] [Abstract][Full Text] [Related]
35. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870 [TBL] [Abstract][Full Text] [Related]
36. Management of systemic sclerosis: the art and science. Stone JH; Wigley FM Semin Cutan Med Surg; 1998 Mar; 17(1):55-64. PubMed ID: 9512108 [TBL] [Abstract][Full Text] [Related]
37. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153 [TBL] [Abstract][Full Text] [Related]
38. [Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]. Juche A; Siegert E; Mueller-Ladner U; Riemekasten G; Günther C; Kötter I; Henes J; Blank N; Voll RE; Ehrchen J; Schmalzing M; Susok L; Schmeiser T; Sunderkoetter C; Distler J; Worm M; Kreuter A; Horváth ON; Schön MP; Korsten P; Zeidler G; Pfeiffer C; Krieg T; Hunzelmann N; Moinzadeh P Z Rheumatol; 2020 Dec; 79(10):1057-1066. PubMed ID: 32040755 [TBL] [Abstract][Full Text] [Related]
39. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines. Reed J; Pope J Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522 [TBL] [Abstract][Full Text] [Related]